¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06
±³À°ÀÏÀÚ : 2024-07-06
±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø CMI, ¼­¼ºÈ¯È¦(1F)

±³À°ÁÖÁ¦ : Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ½Å¿¬±¸È¸

´ã´çÀÚ : ºÎ½Å¿¬±¸È¸ ¿î¿µ»ç¹«±¹
¿¬¶ôó : 010-2125-1225

À̸ÞÀÏ : melissa.hwang1989@gmail.com

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ÀÇ»çÇÐ, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 90¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 30,000¿ø  

ºñ°í (»çÀüµî·Ïºñ :  Àü¹®ÀÇ_20,000¿ø, Àü°øÀÇ/ÀüÀÓÀÇ_10,000¿ø, ¿¬±¸¿ø/°£È£»ç_10,000¿ø, Çлý/ÀÇ·á°ü·ÃŸÁ÷¿ª/ÀϹÝÀÎ_¹«·á  ÇöÀåµî·Ïºñ: Àü¹®ÀÇ_30,000¿ø, Àü°øÀÇ/ÀüÀÓÀÇ_20,000¿ø, ¿¬±¸¿ø/°£È£»ç_20,000¿ø, Çлý/ÀÇ·á°ü·ÃŸÁ÷¿ª/ÀϹÝÀÎ: 10,000¿ø)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 13:00~13:05 Opening Remarks ( )

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 13:05~13:25 Steroid Profiling for Adrenal Diseases: Recent Updates and Insights ÃÖ¸¸È£(KIST)

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 13:25~13:45 Genetic Testing for Bilateral Adrenocortical Diseases ÀÌÁö¼ö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 13:45~14:05 Prediction of Metastatic Pheochromocytoma and Paraganglioma before Surgery À̽ÂÈÆ(¿ï»êÀÇ´ë)

Åä·Ð 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 14:05~14:15 Q&A, Panel Discussion È«¾Æ¶÷ Á¤°æ¿¬ À̽ÃÈÆ(Àü³²ÀÇ´ë À»ÁöÀÇ´ë °¡ÃµÀÇ´ë)

ÈÞ½Ä 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 14:15~14:30 Ä¿ÇǺ극ÀÌÅ© ( )

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 14:30~14:50 Technical Issues about Adrenal Vein Sampling Çѱââ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 14:50~15:10 Functional Imaging for Primary Aldosteronism ÆØÁøö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 15:10~15:30 Image-Guided Radiofrequency Ablation for Adrenal Metastatic Tumors ¹Úº´°ü(¼º±Õ°üÀÇ´ë)

Åä·Ð 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 15:30~15:40 Q&A, Panel Discussion ÀÓÁ¤¼ö ±¸À¯Á¤ ÀÌÁÖÈñ(¿¬¼¼¿øÁÖÀÇ´ë ¼­¿ïÀÇ´ë Ãæ³²ÀÇ´ë)

ÈÞ½Ä 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 15:40~15:55 Ä¿ÇǺ극ÀÌÅ© ( )

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 15:55~16:15 Transperitoneal Adrenalectomy VS. Posterior Retroperitoneal Adrenalectomy ÀÌÁø¿í(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 16:15~16:35 Robotic Adrenalectomy VS. Laparoscopic Adrenalectomy ¼ºÅ¿¬(¿ï»êÀÇ´ë)

Åä·Ð 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 16:35~16:45 Q&A, Panel Discussion ÀÌÀ¯¹Ì ¹ÚÁ¤È¯(¿ï»êÀÇ´ë ÇѾçÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 16:45~17:05 Overview of the 2022 WHO Classification of Adrenal Cortical Overview of the 2022 WHO Classification of Adrenal Cortical Tumors ¼Ûµ¿Àº(¿ï»êÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 17:05~17:25 International Histopathology Consensus for Unilateral Primary Aldosteronism Hironobu Sasano(Tohoku University)

±³À°½Ã°£ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 17:25~17:45 Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas ¿øÀç°æ(¼­¿ïÀÇ´ë)

Åä·Ð 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 17:45~17:55 Q&A, Panel Discussion ±èÁ¤Èñ ¾È¼ºÈñ ÀÌÀ¯ºó(¼­¿ïÀÇ´ë ÀÎÇÏÀÇ´ë ¼º±Õ°üÀÇ´ë)

±âŸ 07¿ù 06ÀÏ ¼­¼ºÈ¯È¦(1F) 17:55~18:00 Ŭ·Î¡ ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06
´ÙÀ½±Û ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
¢Ñ ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 44 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 33 2024-05-28
20896 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 59 2024-05-28
20895 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 42 2024-05-28
20894 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 13 2024-05-28
20893 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 31 2024-05-28
20892 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 35 2024-05-28
20891 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 53 2024-05-28
20890 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 150 2024-05-27
20889 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 85 2024-05-27
20888 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 192 2024-05-27
20887 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 78 2024-05-27
20886 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 36 2024-05-27
20885 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 56 2024-05-27
20884 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 72 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷